Colorectal Cancer Treatment - FOI Response Register

FoI Number
2023-510
Subject
Colorectal Cancer Treatment
Date Received
20/11/2023
Request and Response

I am researching the incidence and treatment of Colorectal Cancer. I would greatly appreciate if you could answer the following question.

  1. In the past 3 months, how many patients have been treated for Colorectal Cancer [CRC] with the following regimens? If possible, please also provide the split of metastatic vs non-metastatic patients for each regimen.

Regimens

Total patients

Metastatic patients

Non-Metastatic patients

Capecitabine

 

 

 

CAPIRI

 

 

 

CAPOX

 

 <5

 <5

Cetuximab with FOLFIRI

 

 <5

 

Cetuximab with FOLFOX

 

 

 

Cetuximab as a single agent

 

 

 

Cetuximab with Encorafenib

 

 

 

Irinotecan as a single agent

 

 <5

 

FOLFIRI

 

 <5

 

FOLFOX

 

 

 

Fluorouracil (5FU) as a single agent

 

 

 

Oxaliplatin as a single agent

 

 

 

Nivolumab with Ipilimumab

 

 

 

Panitumumab with FOLFIRI

 

 

 

Panitumumab with FOLFOX

 

 

 

Panitumumab as a single agent

 

 

 

Pembrolizumab

 

 

 <5

Any other systemic anti-cancer therapy

 

 

 

Palliative care only

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Where we have given <5 answers this is because NHS Shetland considers that providing more specific information carries a high risk of identifying individuals. As such and in accordance with FOISA s 16(1), NHS Shetland confirms that it holds the information requested but that it is exempt from disclosure under FOISA s 38(1)(b) as read with s 38 (2A) as the information constitutes personal data and disclosure would breach the confidentiality of the data subjects.